ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.73
+0.08 (+2.82%)
As of Sep 22, 10:03 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.63M
Net Income
-71,426,597
Gross Margin
Profit Margin
-1,971.7%
Rev Growth
-2.9%
D/E Ratio
0.10
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7%
Operating Margin -1,940.0% -1,746.0% 0.2% 0.2%
Profit Margin -1,971.7% -1,873.1% 0.2% 0.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.63M 3.73M 119.79M 119.57M
Gross Profit 81.15M 81.00M
Operating Income -70,355,777 -65,197,898 217.2K 194.6K
Net Income -71,426,597 -66,190,215 199.8K 200.3K
Gross Margin 67.7% 67.7%
Operating Margin -1,940.0% -1,746.0% 0.2% 0.2%
Profit Margin -1,971.7% -1,873.1% 0.2% 0.2%
Rev Growth -2.9% -2.9% -0.9% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 12.53M 12.53M 114.17M 132.63M
Total Equity 123.84M 123.84M 166.00M 182.25M
D/E Ratio 0.10 0.10 0.69 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -67,749,027 -66,270,156 316.5K 305.4K
Free Cash Flow 248.3K 178.6K